Project Grant K01DA066798
Award Date 9/1/26
Completion Date 8/31/31
Dollars Obligated $194K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Ann Arbor, MI 48109, USA
Similar Awards
- The National Institute on Drug Abuse awarded the Regents of the University of Michigan $701,995 on September 1, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to conduct a National Longitudinal Study of Violence and Substance Use in the United States. The project will develop and implement a nationwide prospective digital cohort of 1,200 adults at increased risk of violence exposure. Participants will complete structured surveys every six months over a 24-month period,...
- The National Institute on Drug Abuse awarded $1.403928 million to the Regents of the University of Michigan on June 15, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to develop and test a remote behavioral economics-based intervention for cannabis use disorder delivered via synchronous videoconferencing. The research addresses the gap between prevalence of cannabis use disorder and treatment access: approximately 22 percent of cannabis users develop the condition, yet...
- The National Institute on Drug Abuse awarded the Regents of the University of Michigan $858,000 on June 1, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to conduct research on substances, behaviors, and outcomes of adolescent reporting to a statewide technology-facilitated reporting system. The research will use mixed natural language processing, statistical, and qualitative methods to analyze tip-level data across six years and conduct qualitative interviews with school...
- The National Institute on Drug Abuse awarded $121,500 to the University of Kansas Center For Research Inc. on December 1, 2025, under the Drug Use and Addiction Research Programs (CFDA 93.279). The research investigates contextual factors influencing cannabis use and behavioral economic demand in naturalistic environments. The project employs ecological momentary assessment and behavioral economic purchase tasks to extend laboratory-based research into real-world settings. The study will conduct...
- The National Institute on Drug Abuse awarded the Regents of the University of Michigan $325,904 on March 1, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to develop real-time machine learning methods for constructing and perturbing stimulus-shaped neural manifolds. The project deliverables span three aims: developing real-time dimensionality reduction algorithms to construct neural manifolds shaped by external stimulus information; designing probabilistic models for...
- The National Institute on Drug Abuse awarded the Research Foundation For Mental Hygiene, Inc. (operating through its New York State Psychiatric Institute division) $195,804 on August 1, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279). The award funds a five-year research project examining how cannabis influences nicotine use among young and emerging adults (ages 18–35) who use electronic nicotine delivery systems. The study integrates human laboratory methods with...
- The National Institute on Drug Abuse awarded the University of Massachusetts $249,000 on July 1, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to conduct longitudinal research examining how minority stress mechanisms mediate cannabis use and cannabis use disorder among sexual minorities. The research leverages ecological momentary assessment to capture real-time measures of daily stressors, cannabis use, and related outcomes in young adults. The study applies the...
- The National Institute on Drug Abuse awarded the Regents of the University of Michigan $386,301 on May 1, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to investigate axonal mechanisms regulating dopamine release in the striatum. The research uses direct recording of axonal voltage to examine how dopaminergic axons control dopamine release, with specific focus on the role of striatal cholinergic interneurons in modulating dopamine availability. The work addresses a gap...
- The National Institute on Drug Abuse awarded the University of Vermont $387,291 on March 1, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to conduct longitudinal research delineating developmental windows of vulnerability for cannabis exposure and assessing causal relationships between cannabis use, neurodevelopment, and behavior. The award funds analysis of three large multimodal neuroimaging datasets spanning preadolescence to late adulthood: ABCD (11,880 participants,...
- The National Institute on Drug Abuse awarded Carnegie Mellon University $191,250 on September 1, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to investigate THC exposure and inhibitory circuit plasticity in the neocortex. The research examines acute and long-term effects of tetrahydrocannabinol (THC), the main psychoactive component of cannabis, on neocortical interneurons expressing the highest levels of cannabinoid receptors in the mammalian brain. The project will...